PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Predicting outcome for high-dose IL-2 therapy in cancer patients

2013-12-02
(Press-News.org) Contact information: Corinne Williams
press_releases@the-jci.org
Journal of Clinical Investigation
Predicting outcome for high-dose IL-2 therapy in cancer patients One of the most potent forms of immunotherapy for patients with metastatic melanoma and renal cell carcinoma is high-dose (HD) bolus IL-2 therapy. Approximately 15% of patients respond to HD IL-2 therapy, with almost 5% going into complete remission; however, use of HD IL-2 therapy is limited due to the toxic effects associated with treatment. Because HD IL-2-associated toxicity is severe, it would be beneficial for clinicians to determine if a patient would respond favorably to this treatment prior to side effect onset. Previous studies indicate that regulatory T cell (Treg) populations increase in patients undergoing HD IL-2 therapy, and in this issue of the Journal of Clinical Investigation, Lazlo Radvanyi and colleagues at M.D. Anderson Cancer Center performed an in depth analysis of Treg populations in melanoma patients undergoing HD IL-2 therapy. The authors identified a distinct population of Treg cells that expressed the inducible T cell costimulator (ICOS) that was highly proliferative following the first cycle of HD IL-2. Furthermore, melanoma patients with greater levels of ICOS+ Tregs in response to HD IL-2 had better clinical outcomes, suggesting that this Treg population may be useful to predict which patients would benefit from HD IL-2.

INFORMATION:

TITLE: IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients

AUTHOR CONTACT: Lazlo Radvanyi
University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Phone: 713.563.9489; E-mail: lradvanyi@mdanderson.org

View this article at: http://www.jci.org/articles/view/46266?key=052e9f45d55cf479c3fe

END



ELSE PRESS RELEASES FROM THIS DATE:

Blocking antioxidants in cancer cells reduces tumor growth in mice

2013-12-02
Blocking antioxidants in cancer cells reduces tumor growth in mice Many cancers have adapted to cope with high levels of immune system-produced free radicals, also referred to as reactive oxygen species, by overproducing antioxidant proteins. One of these ...

Silent RNAs express themselves in ALS disease

2013-12-02
Silent RNAs express themselves in ALS disease RNA molecules, used by cells to make proteins, are generally thought to be "silent" when stowed in cytoplasmic granules. But a protein mutated in some ALS patients forms granules that permit translation of ...

First Nations adults have more than double the risk of end-stage kidney disease

2013-12-02
First Nations adults have more than double the risk of end-stage kidney disease First Nations adults with diabetes have more than double the risk of end-stage kidney disease compared with non–First Nations adults, found a new study in CMAJ (Canadian ...

Johns Hopkins researchers show how a modified pacemaker strengthens failing hearts

2013-12-02
Johns Hopkins researchers show how a modified pacemaker strengthens failing hearts Findings advance opportunities for a 'pacemaker in a bottle' Johns Hopkins heart researchers are unraveling the mystery of how a modified pacemaker used to treat many patients ...

Evolution, Civil War history entwine in plant fossil with a tragic past

2013-12-02
Evolution, Civil War history entwine in plant fossil with a tragic past Union Army forced freed slaves to dig canal where 120 million-year-old fossil plant was found COLLEGE PARK, Md – A fossil leaf fragment collected decades ago on a Virginia canal bank has been identified ...

Key found to restoring 'exhausted' HIV-fighting immune cells

2013-12-02
Key found to restoring 'exhausted' HIV-fighting immune cells Protein could prove a promising new drug target Researchers have identified a protein that causes loss of function in immune cells combatting HIV. The scientists report in a paper appearing online Dec. 2 in ...

New evidence that 'gout' strongly runs in the family

2013-12-02
New evidence that 'gout' strongly runs in the family It's historically known as 'the king of diseases and the disease of kings' and was long thought to be caused by an overindulgent lifestyle, but now scientists at The University of Nottingham have confirmed ...

Researchers analyze growth potential in African bank loans

2013-12-02
Researchers analyze growth potential in African bank loans In Africa, small women-owned business owners find it easier to obtain loans than their male counterparts. The reason for this distortion is that politicians and foreign aid organisations with their focus on bank ...

Congenital heart defects affects long-term developmental outcome

2013-12-02
Congenital heart defects affects long-term developmental outcome Approximately one percent of all newborns in Switzerland are diagnosed with a congenital heart defect, roughly half of them require open heart surgery. Most children, including those with the most severe ...

New research shows obesity is an inflammatory disease

2013-12-02
New research shows obesity is an inflammatory disease New research in The FASEB Journal suggests that an abnormal amount of an inflammatory protein called PAR2 is present on abdominal fat tissues of overweight and obese humans and ...

LAST 30 PRESS RELEASES:

Study unexpectedly finds living in rural, rather than urban environments in first five years of life could be a risk factor for developing type 1 diabetes

Editorial urges deeper focus on heart-lung interactions in pulmonary vascular disease

Five University of Tennessee faculty receive Fulbright Awards

5 advances to protect water sources, availability

OU Scholar awarded Fulbright for Soviet cinema research

Brain might become target of new type 1 diabetes treatments

‘Shore Wars:’ New research aims to resolve coastal conflict between oysters and mangroves, aiding restoration efforts

Why do symptoms linger in some people after an infection? A conversation on post-acute infection syndromes

Study reveals hidden drivers of asthma flare-ups in children

Physicists decode mysterious membrane behavior

New insights about brain receptor may pave way for next-gen mental health drugs

Melanoma ‘sat-nav’ discovery could help curb metastasis

When immune commanders misfire: new insights into rheumatoid arthritis inflammation

SFU researchers develop a new tool that brings blender-like lighting control to any photograph

Pups in tow, Yellowstone-area wolves trek long distances to stay near prey

AI breakthrough unlocks 'new' materials to replace lithium-ion batteries

Making molecules make sense: A regional explanation method reveals structure–property relationships

Partisan hostility, not just policy, drives U.S. protests

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: August 1, 2025

Young human blood serum factors show potential to rejuvenate skin through bone marrow

Large language models reshape the future of task planning

Narrower coverage of MS drugs tied to higher relapse risk

Researchers harness AI-powered protein design to enhance T-cell based immunotherapies

Smartphone engagement during school hours among US youths

Online reviews of health care facilities

MS may begin far earlier than previously thought

New AI tool learns to read medical images with far less data

Announcing XPRIZE Healthspan as Tier 5 Sponsor of ARDD 2025

Announcing Immortal Dragons as Tier 4 Sponsor of ARDD 2025

Reporting guideline for chatbot health advice studies

[Press-News.org] Predicting outcome for high-dose IL-2 therapy in cancer patients